Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bavituximab + Ribavirin in Chronic HCV Genotype 1
NCT01273948Phase 2Completed
- Sponsor
- Avid Bioservices, Inc.
- Start
- Jan 2011
- Primary completion
- Jan 2012
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bavituximab in hepatitis C (HCV), sponsored by Avid Bioservices, Inc.. Started Jan 2011; status: completed.
02
Drugs
bavituximab
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01273948.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01273948.